| Ytd | 8.21% | |
| 1y | -5.08% |
| Open | 13.86 | Prev Close | 13.41 | Low | 13.24 | High | 13.86 | Mkt Cap | 1.05B |
| Vol | 1.23M | Avg Vol | 916.55K | EPS | -0.09 | P/E | N/A | Forward P/E | 5.19 |
| Beta | 1.21 | Short Ratio | 9.84 | Inst. Own | 98.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-21 | 50-d Avg | 16.30 | 200-d Avg | 14.06 | 1yr Est | 18.38 |
IART News
On October 08, 2026, Integra Lifesciences Holdings Corp (IART) shares rose 3.1% to a current price o
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating pot
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for DirectionPR NewswireNEW YORK, Oc
/PRNewswire/ -- Stock Preachers News Commentary - Wall Street closed out the week split down the mid
Integra LifeSciences cut its 2026 financial guidance after a July flood disrupted its Cincinnati fac
BMO Capital analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Market Perform
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law
San Diego, California--(Newsfile Corp. - October 4, 2026) - Johnson Fistel, PLLP, a leading stockhol
Integra LifeSciences (NASDAQ: IART - Get Free Report) issued an update on its FY 2026 earnings guida
/PRNewswire/ -- Stock Preachers News Commentary - Big technology names pulled the Nasdaq Composite t
A $4.3 million to $6.3 million gap between Integra's preliminary third-quarter revenue and the Wall
U.S. stocks rose Friday, led by Nasdaq (+1.27%), despite weak jobs data. Factory orders edged up; oi
Gainers Stablecoin Development (AMEX:SDEV) shares moved upwards by 66.9% to $6.11 during Friday'
Integra Lifesciences Holdings Corp (NASDAQ:IART) cut its 2026 revenue and adjusted earnings guidance
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology compan
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq
Investors interested in stocks from the Medical - Instruments sector have probably already heard of
Integra sees steady Specialty Surgery demand and improving efficiency, but leverage and currency swi
Investors interested in stocks from the Medical - Instruments sector have probably already heard of
Integra LifeSciences (Nasdaq: IART), a leading global medical technology company, announced today th
Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients Prosp
Company to feature surgeon-led educational programming and technologies supporting liver surgery Com
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Wei
Integra Lifesciences (NASDAQ:IART) is looking for Q3 Adj EPS of $0.53-$0.61 vs $0.56 analyst estimat
Integra Lifesciences (NASDAQ:IART) affirms FY2026 Adj EPS guidance from $2.40-$2.50 to $2.40-$2.50 v
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.56 per share which beat the ana
UBS analyst Patrick Wood initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Neutral
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and
BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Ma
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and rai
Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Wei
Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidanc
Integra Lifesciences (NASDAQ:IART) is looking for Q2 Adj EPS of $0.44-$0.52 vs $0.53 analyst estimat
Integra Lifesciences (NASDAQ:IART) raises FY2026 Adj EPS guidance from $2.30-$2.40 to $2.40-$2.50 vs
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the ana
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and
Top Wall Street analysts changed outlook on top names. See all rating changes at https://www.benzing
Wells Fargo analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight a
Integra Lifesciences (NASDAQ:IART) is looking for Q1 Adj EPS of $0.37-$0.45 vs $0.48 analyst estimat
Integra Lifesciences (NASDAQ:IART) is looking for FY2026 Adj EPS of $2.30-$2.40 vs $2.35 analyst est
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.83 per share which beat the ana
FDA warns of high-risk device issue with wound and burn care products by Integra LifeSciences, citin